Getting drugs and devices to the doorstep is only half the battle. When digital connections fail, trials fail. Why the digital last mile needs clinical supply ownership, human-centered design, and tech support with a bedside manner.
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Headed Down Registry Road? Here Are The EDC Features You'll Need
Most of us rely on electronic data capture (EDC) to help us reach our study destination. How do we choose the EDC "vehicle" that will get us there safely, with minimal delays? Consider the relative importance of these key EDC features.
-
Build Better Studies Faster: 3 Advantages Of Mobile eClinical Platforms
Embrace the digital revolution in clinical research with advanced eClinical platforms that expand reach, enhance efficiency, and streamline processes, revolutionizing your trials and work-life balance.
-
Fomenting A Culture Of Analytical Excellence In Clinical Development
Building an "analytics culture" in clinical research requires striking a balance between fast, flexible technologies and the right support for trial teams working to integrate these solutions.
-
Empowering Oncology Research With The Right Technology Solutions
Explore how advanced technology solutions have the potential to simplify the operational aspects of oncology trials.
-
Beginner's Guide To 21 CFR Part 11 Compliance
Computer systems used for clinical trials fall under Food and Drug Administration (FDA) 21 CFR Part 11. While Part 11 is widely known, this blog explains how it fits in with your research software.
-
Single-Arm Trials Use Real-World Evidence For Rare Disease Drug Development
In rare disease product development, where a placebo control group may not be an option, a single-arm trial can be a successful approach. Gain insight into the regulatory considerations for single-arm trials.
-
Leveraging RWD With AI To Enable Diverse Recruitment In Clinical Trials
A diverse cohort of clinical research participants is vital to developing studies that are representative of the target population. Real-world data (RWD) can be paired with AI to integrate unstructured data.
-
How Heron Therapeutics Sped Up Database Creation
Electronic data capture (EDC) is straightforward, in theory. However, not every EDC is purpose-designed for ease of use by study teams, and some are easier to use and more intuitive than others.
-
The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials
Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.
-
Digital Measurement Of Nocturnal Scratch In Atopic Dermatitis
A major challenge in managing atopic dermatitis (AD) is the lack of objective tools to measure the impact of nocturnal scratching, but new digital measurement solutions could address this gap.